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CRD commentary

Interventions:
Patients on the waiting list did not receive the intervention, and presumably received standard care. This was useful for local decision-making, but as this care was not described it is unclear how relevant it would be to other settings. The interventions were clearly for use at home; another option, to alleviate caregiver difficulties, would be to move patients with dementia into an institution -this was not considered.
Effectiveness/benefits:
The outcomes were only two of four outcomes from the Caregiver Vigilance Scale. It was unclear why the other two outcomes were not used, and what these outcomes were. Another publication was referenced, but the details of the clinical trial were not reported. The authors attempted to adjust for baseline differences, but this was crudely done, and was not likely to have accounted for differences in the final outcomes due to initial differences. Two measures of benefit were used; these could have been combined as both measured time, and this would have reduced the costeffectiveness of the intervention. As time was the measure of benefit, carer time and hardship could have been given a monetary value in a cost-benefit analysis, as acknowledged by the authors. The outcomes did not assess patient benefits, which could be important to the caregiver, beyond their own time benefits.
Costs:
Only the cost of the intervention was calculated, and so the control group had no cost. There may have been other costs incurred by caregivers or the health system that were affected by the intervention. This could have underestimated the benefit of the TAP. The intervention costs appear to have been applicable to the setting. The perspective was that of the caregiver, but it was unclear if the caregiver would pay the intervention costs. The authors acknowledged that their costing perspective was limited; they indicated that a societal perspective with objective health care use and potential caregiver productivity losses would have been more appropriate. The price year was not stated, making reproduction of the results difficult.
Analysis and results:
The chosen cost-effectiveness threshold was a little difficult to interpret. If the caregiver paid for the intervention, then using the cost of housekeeping to determine whether or not paying for the intervention broke even was appropriate. The methods for the probabilistic analysis were not described. It is likely that it was conducted by sampling from the individual patient data, but this was not explicitly stated. It was unclear whether the analysis was conducted appropriately, making the validity of the results uncertain. The authors acknowledged several limitations, such as the study had a short follow-up that may not have captured the long-term benefits and adherence; and it was small and most participants were White.
